A therapy using magnetic impulses may be able to bring people suffering from long-term dementia back to the land of the living.
Piece by piece the world sinks away until nothing remains but a cheerless, bleak island on which you are left stranded, searching in vain for the person you were. What remains of a person no longer in tune with his or her environment; just sitting there like an empty shell?
Just under 30 million people worldwide are affected by Alzheimer’s to varying degrees—and it is thought that this figure will quadruple by 2050. In Germany alone there are more than 10,000 care homes, mainly for elderly people suffering from dementia. Quite apart from the fact that this lethargic stagnation not only robs the person of his or her dignity and is deeply painful for their relatives to watch, the growing incidence of senile dementia is costing our aging population increasingly more money; a situation that experts warn could soon explode.
The causes of Alzheimer’s are still not fully understood. As is so frequently the case in these instances, conventional medicine holds that genetic mutations are to blame. These mutations allegedly lead to plaque forming on the nerve cord surfaces in the brain, which consist of beta-amyloid peptides that have folded abnormally. The pharmaceutical industry quickly developed a vaccine against Alzheimer’s, which indeed removed such plaque in the brains of those affected. Yet the vaccinated Alzheimer’s patients only got worse, suggesting that the mis-folded proteins in the brain could not be the actual cause.
In fact, there are a few known reasons for dementia—but powerful interest groups don’t want to talk about them. Chief among these is the microwave radiation caused by mobile telephony, which may also trigger Alzheimer’s in young people, and whose specific mechanisms have long been documented. Vaccines containing auxiliary substances (such as mercury!) that are highly detrimental to health must also be mentioned at this point; as well as an ostensibly minor thing like drinking too little water. We cannot disregard the mental element, either: a rolling stone gathers no moss, as the saying appropriately goes. We must occupy our ‘little grey cells’ if we want to reach a grand old age compos mentis. Making music, brain jogging, reading, thinking, playing, etc. are all beneficial—and not on your own, but in company: social contact is just as important in order not to drift into isolation and ensuing depression—an emotional sickness that is common in dementia patients.
Hard to believe, but true, that hospitals have only recently come under the radar of Alzheimer researchers. In February 2010 a study published by the American Medical Association and carried out by the University of Washington concluded that elderly people (over 65) almost doubled their risk of developing senile dementia if they entered hospital care. In comparison to those who had not been previously hospitalised, the Alzheimer’s rate was 40% higher!
The medication administered could be responsible for this. At about the same time, the British health organisation WDDTY published a report which stated that ordinary, often non-prescription, medicines could trigger symptoms typical of Alzheimer’s disease, for example loss of short-term memory or certain words. To blame are the nerve-blocking substances frequently contained in pharmaceutical drugs, which have a so-called “anticholinergic effect”.
This article does not intend to go into the causes of Alzheimer’s; we are more interested in its treatment, indeed even potential cure! Not only is it possible to delay or stop the degenerative course of dementia, it may even be possible to reverse it—just not by conventional methods. And absolutely not by vaccinations.
You may be wondering why you’ve never heard of the aforementioned Alzheimer’s vaccine, and for good reason: the initial euphoria surrounding it had already ebbed even before the vaccine could be approved for sale due to the side effects, which included dizzy spells, disturbed mobility and altered awareness. It often even provoked a kind of meningitis, which could not be treated with cortisone in all cases. The clinical trial was thus halted prematurely, and it was announced that Alzheimer’s wasn’t “yet treatable”.1 Print media and the TV all joined in and now repeatedly drill into us the idea that “You can’t cure Alzheimer’s”.2
The Munich non-fiction writer Georges Bourbaki has campaigned tirelessly for many years for a promising therapy for dementia sufferers. His crusade against forgetfulness was prompted by his mother, whose inexorable slide into Alzheimer’s deeply affected him. Today Bourbaki is himself an elderly gentleman of 75, who says fate had “deliberately placed a little Alzheimer’s egg in my own nest.” His own treatment lasted just two months, from August to September 2009, until all the symptoms of senile dementia had completely disappeared—yet probably not forgotten!
“Before, I had started to suffer from dreadful mental deficits, for example I would forget things that you really shouldn’t, or I would no longer remember familiar street names, etc.,” Bourbaki recalls. “Fortunately, I had a friend who pointed out my mental lapses.”
His previous dealings with the subject of Alzheimer’s meant that Georges Bourbaki had already acquired from Greek professor Panagiotis Pappas a magnetic impulse device known as PAP-IMI (similar devices are the Rehatron or Theracell). For about half an hour every day Bourbaki wore a magnetic coil linked to the device on his head; after just a few weeks, all signs of Alzheimer’s had gone.
It was about this time that Bourbaki stumbled across a small advertisement in the Münchner Abendzeitung (Munich Evening Paper) in which German TV channel ZDF was looking for people with dementia willing to have the course of their disease documented on film. In naive enthusiasm, he registered immediately and explained that he had been able to cure the initial stages of Alzheimer’s completely—at which the science journalist on the other end of the line bluntly replied that this claim rendered Bourbaki ineligible. Even the many well-documented and equally successful therapy cases from across the world wouldn’t change the editor’s mind. “I could have given him as many cases as I wanted; he still wouldn’t believe me,” recalls Bourbaki.
So the persistent pensioner issued a formal complaint with ZDF, and in November 2009 he received a letter from ZDF director Markus Schächter, which read: “Our research into the magnetic impulse therapy you described tells us that there isn’t yet enough scientific data to substantiate your claims and therefore no general recommendation can be given. We therefore see no occasion for a report at this time.”
An excuse that’s as old as corrupt science itself. And in this case it doesn’t really add up. Take doctor, psychiatrist and psychotherapist Dr. Oliver Seemann, who today runs a successful practice in rural Bavaria, Germany, and also practises in the city of Munich. In March 2002 he was able to treat an Alzheimer’s patient successfully with magnetic stimulation for the first time. Two years later the personal physician to Pope John Paul II also became interested in this form of energy medicine and came knocking at Seemann’s door. Today the doctor is one of the leading experts in the field of rTMS, or repetitive transcranial magnetic stimulation—essentially, repeated stimulation of the brain by magnets positioned near the head.
To date, Oliver Seemann has been able to treat “more than 200 patients with Alzheimer’s and frontotemporal dementia as well as vascular dementia,” in which very positive results using rTMS have been demonstrated. “In particular, this treatment had a positive effect on language skills, cognitive abilities, concentration and attention as well as general well-being in most patients. In some cases, it resulted in markedly increased social interest with improved ability to establish contact.”
According to Seemann, his success rate lies at over 80 per cent—remarkable for an allegedly incurable disease.